 Roberta Pelanda
Concepts (394)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 53 | 2024 | 815 | 8.480 |
Why?
| | Receptors, Antigen, B-Cell | 28 | 2023 | 126 | 4.830 |
Why?
| | Autoimmunity | 11 | 2022 | 862 | 2.730 |
Why?
| | Central Tolerance | 4 | 2022 | 10 | 2.700 |
Why?
| | Cell Differentiation | 17 | 2024 | 1902 | 2.620 |
Why?
| | Immune Tolerance | 10 | 2025 | 355 | 2.530 |
Why?
| | Precursor Cells, B-Lymphoid | 6 | 2023 | 38 | 2.180 |
Why?
| | Autoantibodies | 11 | 2022 | 1466 | 1.580 |
Why?
| | Lupus Erythematosus, Systemic | 3 | 2022 | 247 | 1.440 |
Why?
| | B-Lymphocyte Subsets | 6 | 2018 | 74 | 1.390 |
Why?
| | Plasma Cells | 2 | 2024 | 67 | 1.280 |
Why?
| | T-Lymphocytes | 11 | 2022 | 1928 | 1.220 |
Why?
| | Mice | 65 | 2025 | 16937 | 1.120 |
Why?
| | Autoantigens | 7 | 2021 | 417 | 1.110 |
Why?
| | Phosphatidylinositol 3-Kinases | 4 | 2024 | 359 | 1.070 |
Why?
| | Cell Proliferation | 6 | 2024 | 2391 | 1.020 |
Why?
| | Animals | 74 | 2025 | 35360 | 0.950 |
Why?
| | Proto-Oncogene Proteins c-maf | 1 | 2024 | 2 | 0.930 |
Why?
| | Receptors, CXCR4 | 2 | 2024 | 83 | 0.930 |
Why?
| | Germinal Center | 2 | 2024 | 57 | 0.900 |
Why?
| | Signal Transduction | 18 | 2023 | 4925 | 0.900 |
Why?
| | Forkhead Box Protein O1 | 1 | 2024 | 21 | 0.900 |
Why?
| | Spleen | 9 | 2024 | 507 | 0.860 |
Why?
| | Alleles | 5 | 2024 | 845 | 0.850 |
Why?
| | Mice, Knockout | 20 | 2024 | 2871 | 0.850 |
Why?
| | Mice, Transgenic | 15 | 2021 | 2119 | 0.750 |
Why?
| | Immunoglobulin Light Chains | 7 | 2014 | 40 | 0.740 |
Why?
| | Mice, Inbred BALB C | 15 | 2021 | 1245 | 0.740 |
Why?
| | Antibody Formation | 5 | 2018 | 290 | 0.690 |
Why?
| | Models, Animal | 4 | 2019 | 376 | 0.680 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 7 | 0.640 |
Why?
| | Immune System | 3 | 2021 | 175 | 0.640 |
Why?
| | CD8-Positive T-Lymphocytes | 7 | 2025 | 857 | 0.630 |
Why?
| | Bone Marrow Cells | 5 | 2022 | 300 | 0.600 |
Why?
| | Mice, Inbred C57BL | 20 | 2025 | 5440 | 0.570 |
Why?
| | B-Cell Activation Factor Receptor | 5 | 2018 | 13 | 0.570 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 3 | 2018 | 169 | 0.560 |
Why?
| | Mice, Inbred MRL lpr | 4 | 2022 | 38 | 0.540 |
Why?
| | Lysophospholipids | 4 | 2023 | 72 | 0.540 |
Why?
| | Lymphocyte Activation | 9 | 2025 | 1106 | 0.540 |
Why?
| | Antigens, CD | 7 | 2015 | 489 | 0.540 |
Why?
| | MAP Kinase Signaling System | 1 | 2018 | 312 | 0.500 |
Why?
| | Flow Cytometry | 10 | 2022 | 1156 | 0.500 |
Why?
| | Bone Marrow | 5 | 2023 | 271 | 0.480 |
Why?
| | Receptors, Lysophosphatidic Acid | 6 | 2023 | 30 | 0.450 |
Why?
| | Immunoglobulin kappa-Chains | 6 | 2015 | 20 | 0.440 |
Why?
| | Gene Rearrangement, B-Lymphocyte | 4 | 2007 | 7 | 0.430 |
Why?
| | ras Proteins | 1 | 2014 | 144 | 0.420 |
Why?
| | Immunoglobulin M | 7 | 2023 | 275 | 0.420 |
Why?
| | Receptors, Cytokine | 1 | 2013 | 35 | 0.410 |
Why?
| | Tumor Virus Infections | 2 | 2012 | 46 | 0.410 |
Why?
| | Immunoglobulins | 3 | 2012 | 159 | 0.400 |
Why?
| | Glucocorticoid-Induced TNFR-Related Protein | 1 | 2012 | 5 | 0.390 |
Why?
| | Rhadinovirus | 1 | 2012 | 20 | 0.390 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 3 | 2002 | 13 | 0.380 |
Why?
| | Peripheral Tolerance | 3 | 2022 | 15 | 0.380 |
Why?
| | Guanine Nucleotide Exchange Factors | 5 | 2011 | 63 | 0.370 |
Why?
| | Interleukin Receptor Common gamma Subunit | 1 | 2011 | 14 | 0.370 |
Why?
| | Transplantation Chimera | 1 | 2011 | 54 | 0.360 |
Why?
| | Immunologic Memory | 2 | 2013 | 349 | 0.360 |
Why?
| | Immunoglobulin Heavy Chains | 7 | 2013 | 80 | 0.360 |
Why?
| | Lymph Nodes | 2 | 2013 | 472 | 0.350 |
Why?
| | Herpesviridae Infections | 1 | 2012 | 141 | 0.350 |
Why?
| | Genetic Variation | 1 | 2015 | 937 | 0.350 |
Why?
| | Immunoglobulin G | 4 | 2024 | 847 | 0.340 |
Why?
| | Cytokines | 4 | 2023 | 2017 | 0.340 |
Why?
| | Genes, Immunoglobulin | 5 | 2000 | 28 | 0.330 |
Why?
| | Disease Models, Animal | 11 | 2025 | 4063 | 0.310 |
Why?
| | Immunity, Humoral | 3 | 2014 | 118 | 0.300 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2021 | 573 | 0.290 |
Why?
| | Immunoglobulin Allotypes | 1 | 2007 | 9 | 0.280 |
Why?
| | DNA-Binding Proteins | 5 | 2011 | 1443 | 0.280 |
Why?
| | Immunoglobulin Variable Region | 6 | 2007 | 79 | 0.280 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2020 | 197 | 0.270 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2548 | 0.270 |
Why?
| | Transgenes | 2 | 2018 | 177 | 0.260 |
Why?
| | Antigens, CD19 | 4 | 2015 | 115 | 0.260 |
Why?
| | Immunologic Surveillance | 2 | 2025 | 26 | 0.260 |
Why?
| | Immunoglobulin Joining Region | 4 | 2002 | 10 | 0.260 |
Why?
| | Integrases | 3 | 2006 | 119 | 0.260 |
Why?
| | RNA Editing | 1 | 2005 | 20 | 0.250 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 833 | 0.250 |
Why?
| | Immunoglobulin Isotypes | 2 | 2022 | 34 | 0.240 |
Why?
| | Antibodies, Neutralizing | 3 | 2020 | 265 | 0.240 |
Why?
| | Humans | 33 | 2023 | 129622 | 0.240 |
Why?
| | Antigens | 3 | 2013 | 355 | 0.240 |
Why?
| | Hybridomas | 3 | 2012 | 234 | 0.230 |
Why?
| | Biliary Atresia | 2 | 2018 | 161 | 0.220 |
Why?
| | Cells, Cultured | 8 | 2019 | 4083 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 4 | 2010 | 638 | 0.220 |
Why?
| | Cell Separation | 4 | 2018 | 316 | 0.220 |
Why?
| | Neoplasms | 3 | 2022 | 2470 | 0.210 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2023 | 26 | 0.200 |
Why?
| | HIV-1 | 2 | 2020 | 836 | 0.200 |
Why?
| | CD79 Antigens | 4 | 2018 | 15 | 0.200 |
Why?
| | Enzyme Activation | 2 | 2018 | 811 | 0.200 |
Why?
| | Female | 12 | 2024 | 68770 | 0.200 |
Why?
| | Tumor Microenvironment | 3 | 2022 | 634 | 0.200 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2025 | 272 | 0.200 |
Why?
| | Immunological Synapses | 1 | 2022 | 16 | 0.190 |
Why?
| | Models, Immunological | 3 | 2018 | 95 | 0.190 |
Why?
| | Carcinogenesis | 3 | 2019 | 213 | 0.190 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 380 | 0.190 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 2 | 2020 | 211 | 0.180 |
Why?
| | Homeostasis | 2 | 2018 | 611 | 0.180 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2023 | 1198 | 0.180 |
Why?
| | Heterografts | 1 | 2021 | 131 | 0.170 |
Why?
| | Adaptive Immunity | 2 | 2018 | 161 | 0.170 |
Why?
| | Cell Membrane | 1 | 2004 | 732 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 431 | 0.170 |
Why?
| | Mice, Mutant Strains | 3 | 2012 | 298 | 0.170 |
Why?
| | Male | 10 | 2025 | 63674 | 0.170 |
Why?
| | Quinoxalines | 1 | 2020 | 65 | 0.170 |
Why?
| | Immunotherapy | 2 | 2022 | 592 | 0.170 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 399 | 0.170 |
Why?
| | Immunoglobulin lambda-Chains | 2 | 2015 | 6 | 0.160 |
Why?
| | Liver Neoplasms | 1 | 2025 | 640 | 0.160 |
Why?
| | Viral Proteins | 1 | 2002 | 328 | 0.160 |
Why?
| | Endothelial Cells | 1 | 2025 | 749 | 0.160 |
Why?
| | Cell Survival | 4 | 2018 | 1086 | 0.160 |
Why?
| | Age Factors | 3 | 2013 | 3144 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 130 | 0.150 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 200 | 0.150 |
Why?
| | beta Catenin | 1 | 2020 | 223 | 0.150 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2019 | 169 | 0.150 |
Why?
| | Stem Cells | 2 | 2002 | 577 | 0.150 |
Why?
| | Lymphopoiesis | 1 | 2018 | 25 | 0.150 |
Why?
| | Liver | 2 | 2025 | 1839 | 0.150 |
Why?
| | Immunity, Innate | 2 | 2018 | 804 | 0.150 |
Why?
| | Receptors, Complement 3d | 1 | 2019 | 140 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 67 | 0.150 |
Why?
| | Piperazines | 1 | 2020 | 342 | 0.150 |
Why?
| | Xenograft Model Antitumor Assays | 4 | 2022 | 814 | 0.150 |
Why?
| | Retroviridae | 1 | 2018 | 99 | 0.140 |
Why?
| | Transduction, Genetic | 1 | 2018 | 128 | 0.140 |
Why?
| | Antibodies | 3 | 2015 | 398 | 0.140 |
Why?
| | Herpesvirus 4, Human | 1 | 2018 | 153 | 0.140 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2018 | 94 | 0.140 |
Why?
| | Allergens | 1 | 2020 | 385 | 0.140 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2019 | 209 | 0.140 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 112 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2019 | 232 | 0.130 |
Why?
| | Membrane Glycoproteins | 2 | 2015 | 474 | 0.130 |
Why?
| | Interleukins | 1 | 2018 | 241 | 0.130 |
Why?
| | Genetic Vectors | 1 | 2018 | 312 | 0.130 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 181 | 0.130 |
Why?
| | B-Cell Activating Factor | 2 | 2018 | 21 | 0.130 |
Why?
| | HIV Infections | 3 | 2020 | 2720 | 0.120 |
Why?
| | Phenotype | 2 | 2021 | 3076 | 0.120 |
Why?
| | Genes, bcl-2 | 2 | 2018 | 21 | 0.120 |
Why?
| | Histones | 1 | 2020 | 588 | 0.120 |
Why?
| | Receptors, Lysosphingolipid | 3 | 2010 | 13 | 0.120 |
Why?
| | Antibody Affinity | 2 | 2012 | 59 | 0.120 |
Why?
| | VDJ Recombinases | 3 | 2004 | 4 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2019 | 704 | 0.120 |
Why?
| | Heart Transplantation | 1 | 2021 | 721 | 0.120 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1356 | 0.110 |
Why?
| | Graft Rejection | 2 | 2021 | 598 | 0.110 |
Why?
| | Immunophenotyping | 1 | 2015 | 311 | 0.110 |
Why?
| | Macrophages, Peritoneal | 2 | 2011 | 91 | 0.110 |
Why?
| | Fibronectins | 2 | 2011 | 123 | 0.110 |
Why?
| | Toll-Like Receptors | 2 | 2020 | 179 | 0.110 |
Why?
| | Rotavirus | 1 | 2013 | 20 | 0.110 |
Why?
| | Gene Targeting | 2 | 2006 | 82 | 0.110 |
Why?
| | Animals, Newborn | 2 | 2018 | 835 | 0.110 |
Why?
| | Adoptive Transfer | 2 | 2013 | 218 | 0.110 |
Why?
| | Azospirillum brasilense | 1 | 1993 | 1 | 0.100 |
Why?
| | Glutamate Synthase | 1 | 1993 | 2 | 0.100 |
Why?
| | Antibody Diversity | 3 | 2007 | 16 | 0.100 |
Why?
| | Clonal Selection, Antigen-Mediated | 1 | 2012 | 4 | 0.100 |
Why?
| | Lymphocyte Count | 1 | 2013 | 148 | 0.100 |
Why?
| | Kinetics | 3 | 2012 | 1642 | 0.100 |
Why?
| | HIV Antibodies | 1 | 2013 | 57 | 0.100 |
Why?
| | Genes, Bacterial | 1 | 1993 | 157 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2013 | 131 | 0.100 |
Why?
| | Toll-Like Receptor 7 | 1 | 2012 | 38 | 0.100 |
Why?
| | fas Receptor | 1 | 2012 | 95 | 0.100 |
Why?
| | Rho Guanine Nucleotide Exchange Factors | 5 | 2011 | 22 | 0.100 |
Why?
| | Receptors, Thromboxane | 1 | 2011 | 4 | 0.100 |
Why?
| | Lupus Nephritis | 1 | 2012 | 49 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 2061 | 0.100 |
Why?
| | Transplantation, Homologous | 1 | 2013 | 401 | 0.090 |
Why?
| | Immunoglobulin mu-Chains | 2 | 2004 | 9 | 0.090 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2015 | 442 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2022 | 588 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 752 | 0.090 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2015 | 432 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 3 | 2011 | 381 | 0.090 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2011 | 119 | 0.090 |
Why?
| | Cell Communication | 1 | 2013 | 301 | 0.090 |
Why?
| | Dendritic Cells | 2 | 2012 | 478 | 0.090 |
Why?
| | Cholestasis | 1 | 2013 | 232 | 0.090 |
Why?
| | Reperfusion Injury | 1 | 2013 | 272 | 0.090 |
Why?
| | Friend murine leukemia virus | 1 | 2010 | 29 | 0.090 |
Why?
| | Cytidine Deaminase | 1 | 2010 | 57 | 0.090 |
Why?
| | Integrin alpha5beta1 | 1 | 2010 | 10 | 0.080 |
Why?
| | Self Tolerance | 1 | 2010 | 27 | 0.080 |
Why?
| | Proprotein Convertases | 1 | 2010 | 15 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1565 | 0.080 |
Why?
| | Integrins | 2 | 2007 | 94 | 0.080 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2010 | 137 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2021 | 5762 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2010 | 118 | 0.080 |
Why?
| | Matrix Metalloproteinases | 1 | 2010 | 90 | 0.080 |
Why?
| | Kidney Diseases | 1 | 2013 | 384 | 0.080 |
Why?
| | Immunity | 1 | 2010 | 139 | 0.080 |
Why?
| | Immunity, Active | 1 | 2008 | 10 | 0.080 |
Why?
| | Interferon-alpha | 1 | 2010 | 194 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2023 | 720 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 426 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2013 | 2832 | 0.080 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Light Chain | 2 | 1998 | 4 | 0.080 |
Why?
| | Macrophages, Alveolar | 1 | 2011 | 389 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2010 | 769 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 683 | 0.070 |
Why?
| | Virus Replication | 1 | 2010 | 451 | 0.070 |
Why?
| | Recombination, Genetic | 4 | 2006 | 190 | 0.070 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2007 | 19 | 0.070 |
Why?
| | YY1 Transcription Factor | 1 | 2007 | 28 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2013 | 672 | 0.070 |
Why?
| | Cell Line | 3 | 2020 | 2781 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2007 | 105 | 0.070 |
Why?
| | Melanoma | 1 | 2013 | 730 | 0.070 |
Why?
| | I-kappa B Kinase | 1 | 2006 | 53 | 0.060 |
Why?
| | Th2 Cells | 1 | 2007 | 171 | 0.060 |
Why?
| | Binding Sites, Antibody | 1 | 2005 | 42 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2019 | 3215 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2006 | 161 | 0.060 |
Why?
| | Rats | 1 | 2014 | 5499 | 0.060 |
Why?
| | Kidney | 1 | 2013 | 1385 | 0.060 |
Why?
| | Diethylnitrosamine | 1 | 2025 | 7 | 0.060 |
Why?
| | HIV Envelope Protein gp120 | 2 | 2017 | 57 | 0.060 |
Why?
| | Carbon Tetrachloride | 1 | 2025 | 13 | 0.060 |
Why?
| | DNA Nucleotidyltransferases | 2 | 2002 | 11 | 0.060 |
Why?
| | Lymphoma, B-Cell | 1 | 2006 | 105 | 0.060 |
Why?
| | src-Family Kinases | 1 | 2005 | 96 | 0.060 |
Why?
| | Immunoglobulin Class Switching | 2 | 2010 | 19 | 0.060 |
Why?
| | Cell Movement | 2 | 2008 | 945 | 0.060 |
Why?
| | Cell Division | 2 | 2004 | 797 | 0.060 |
Why?
| | Clonal Deletion | 1 | 2004 | 16 | 0.060 |
Why?
| | Base Sequence | 3 | 2004 | 2142 | 0.060 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2015 | 138 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 1999 | 821 | 0.050 |
Why?
| | Monitoring, Immunologic | 1 | 2023 | 23 | 0.050 |
Why?
| | Mutagenesis | 1 | 2004 | 181 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2004 | 183 | 0.050 |
Why?
| | Immunoglobulin D | 1 | 2022 | 29 | 0.050 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 2 | 2014 | 88 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2025 | 280 | 0.050 |
Why?
| | Transplantation, Heterologous | 1 | 2022 | 192 | 0.050 |
Why?
| | Lectins, C-Type | 2 | 2014 | 71 | 0.050 |
Why?
| | Crosses, Genetic | 1 | 2002 | 142 | 0.050 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2022 | 31 | 0.050 |
Why?
| | NF-kappa B | 1 | 2006 | 653 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2013 | 372 | 0.050 |
Why?
| | Leukosialin | 2 | 1999 | 14 | 0.050 |
Why?
| | Pneumonia | 1 | 2007 | 616 | 0.050 |
Why?
| | Inflammation | 2 | 2022 | 2736 | 0.050 |
Why?
| | Chimerism | 1 | 2021 | 31 | 0.050 |
Why?
| | Phosphorylation | 1 | 2005 | 1713 | 0.040 |
Why?
| | Interferons | 1 | 2022 | 194 | 0.040 |
Why?
| | Sialoglycoproteins | 2 | 1999 | 155 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 958 | 0.040 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 67 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2022 | 183 | 0.040 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 84 | 0.040 |
Why?
| | Hemagglutination | 1 | 2020 | 8 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 351 | 0.040 |
Why?
| | COS Cells | 1 | 2020 | 185 | 0.040 |
Why?
| | Homozygote | 1 | 2000 | 193 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2006 | 1119 | 0.040 |
Why?
| | RNA, Viral | 1 | 2023 | 619 | 0.040 |
Why?
| | Perforin | 1 | 2019 | 19 | 0.040 |
Why?
| | Heterozygote | 1 | 2000 | 272 | 0.040 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 2019 | 46 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2058 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 88 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 940 | 0.040 |
Why?
| | Viral Tropism | 1 | 2018 | 29 | 0.040 |
Why?
| | Antibodies, Anti-Idiotypic | 1 | 2018 | 57 | 0.040 |
Why?
| | Antigens, Nuclear | 1 | 1998 | 20 | 0.040 |
Why?
| | Lipopolysaccharides | 2 | 2015 | 875 | 0.040 |
Why?
| | Virus Activation | 1 | 2018 | 88 | 0.040 |
Why?
| | Virus Latency | 1 | 2018 | 84 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2022 | 601 | 0.040 |
Why?
| | Immunization | 1 | 2020 | 411 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1997 | 65 | 0.040 |
Why?
| | Leukocyte Common Antigens | 1 | 1997 | 82 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1040 | 0.040 |
Why?
| | Tamoxifen | 1 | 2018 | 200 | 0.040 |
Why?
| | Antibody Specificity | 2 | 2013 | 184 | 0.030 |
Why?
| | Cross Reactions | 1 | 2017 | 132 | 0.030 |
Why?
| | HIV | 1 | 2018 | 226 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 352 | 0.030 |
Why?
| | Immunoglobulin Light Chains, Surrogate | 1 | 1996 | 1 | 0.030 |
Why?
| | Lung | 1 | 2010 | 3931 | 0.030 |
Why?
| | DNA Helicases | 1 | 1998 | 149 | 0.030 |
Why?
| | Green Fluorescent Proteins | 2 | 2011 | 385 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 345 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 429 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 504 | 0.030 |
Why?
| | Cell Adhesion | 2 | 2007 | 452 | 0.030 |
Why?
| | Syk Kinase | 1 | 2015 | 21 | 0.030 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2015 | 37 | 0.030 |
Why?
| | Genes, Reporter | 2 | 2006 | 267 | 0.030 |
Why?
| | GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2014 | 7 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2014 | 27 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 88 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 212 | 0.030 |
Why?
| | Neoplastic Processes | 1 | 2013 | 4 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1698 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1367 | 0.030 |
Why?
| | Chromosomes, Bacterial | 1 | 1993 | 8 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 1998 | 663 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 75 | 0.030 |
Why?
| | Macrophages | 1 | 2021 | 1480 | 0.030 |
Why?
| | Antigen-Presenting Cells | 1 | 2013 | 150 | 0.030 |
Why?
| | Genes, Immunoglobulin Heavy Chain | 1 | 2013 | 10 | 0.030 |
Why?
| | Operon | 1 | 1993 | 64 | 0.030 |
Why?
| | Calcium | 1 | 2019 | 1213 | 0.030 |
Why?
| | AIDS Vaccines | 1 | 2013 | 47 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 1993 | 213 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1993 | 524 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2011 | 90 | 0.020 |
Why?
| | Autocrine Communication | 1 | 2011 | 43 | 0.020 |
Why?
| | Apoptosis | 1 | 2020 | 2503 | 0.020 |
Why?
| | Species Specificity | 1 | 2013 | 575 | 0.020 |
Why?
| | Ficoll | 1 | 2010 | 5 | 0.020 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 375 | 0.020 |
Why?
| | Toll-Like Receptor 3 | 1 | 2010 | 27 | 0.020 |
Why?
| | Retroviridae Infections | 1 | 2010 | 46 | 0.020 |
Why?
| | Poly I-C | 1 | 2010 | 62 | 0.020 |
Why?
| | Arthritis, Rheumatoid | 1 | 1999 | 1092 | 0.020 |
Why?
| | Receptors, IgG | 1 | 2010 | 74 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 326 | 0.020 |
Why?
| | Escherichia coli | 1 | 1993 | 774 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 287 | 0.020 |
Why?
| | DNA Methylation | 2 | 2007 | 607 | 0.020 |
Why?
| | Leukocytes | 1 | 2010 | 304 | 0.020 |
Why?
| | Epitopes | 1 | 2010 | 470 | 0.020 |
Why?
| | Cell Membrane Structures | 1 | 2007 | 6 | 0.020 |
Why?
| | RGS Proteins | 1 | 2007 | 16 | 0.020 |
Why?
| | Respiratory Function Tests | 1 | 2010 | 586 | 0.020 |
Why?
| | Vaccines | 1 | 2013 | 397 | 0.020 |
Why?
| | Ligands | 1 | 2010 | 622 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2007 | 122 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1492 | 0.020 |
Why?
| | Gene Expression | 2 | 2006 | 1472 | 0.020 |
Why?
| | PAX5 Transcription Factor | 1 | 2007 | 14 | 0.020 |
Why?
| | Molecular Weight | 1 | 2007 | 332 | 0.020 |
Why?
| | Bronchial Provocation Tests | 1 | 2007 | 51 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2010 | 644 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2007 | 132 | 0.020 |
Why?
| | Cell Polarity | 1 | 2007 | 140 | 0.020 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 221 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2006 | 17 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2010 | 764 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2006 | 32 | 0.020 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2006 | 22 | 0.020 |
Why?
| | Interleukin-7 | 1 | 2006 | 59 | 0.020 |
Why?
| | Genetic Markers | 1 | 2007 | 338 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 428 | 0.020 |
Why?
| | Protein Kinase C-delta | 1 | 2006 | 44 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 315 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2006 | 113 | 0.020 |
Why?
| | Hyperplasia | 1 | 2006 | 171 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 1999 | 1038 | 0.020 |
Why?
| | Genotype | 1 | 2010 | 1839 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2007 | 840 | 0.020 |
Why?
| | Gene Deletion | 1 | 2006 | 379 | 0.010 |
Why?
| | Cell Lineage | 1 | 2006 | 333 | 0.010 |
Why?
| | DNA Nucleotidylexotransferase | 1 | 2004 | 12 | 0.010 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2004 | 8 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 2004 | 94 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 10518 | 0.010 |
Why?
| | Chromatin | 1 | 2007 | 479 | 0.010 |
Why?
| | Cell Nucleus | 1 | 2006 | 582 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2004 | 175 | 0.010 |
Why?
| | DNA Primers | 1 | 2004 | 510 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2006 | 388 | 0.010 |
Why?
| | Extracellular Matrix Proteins | 1 | 2004 | 144 | 0.010 |
Why?
| | Epigenesis, Genetic | 1 | 2007 | 613 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 636 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2004 | 495 | 0.010 |
Why?
| | Epitopes, B-Lymphocyte | 1 | 1999 | 16 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 20391 | 0.010 |
Why?
| | Child | 1 | 2018 | 20882 | 0.010 |
Why?
| | Ku Autoantigen | 1 | 1998 | 13 | 0.010 |
Why?
| | Organ Specificity | 1 | 1999 | 296 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1997 | 12 | 0.010 |
Why?
| | Antigen Presentation | 1 | 1999 | 206 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 1999 | 148 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 1998 | 177 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1999 | 779 | 0.010 |
Why?
|
|
Pelanda's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|